TransMedics Group, Inc. (TMDX)Healthcare | Medical Devices | Andover, United States | NasdaqGM
88.43 USD
-3.32
(-3.619%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 88.62 +0.19 (0.220%) ⇧ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:49 a.m. EDT
The recent price surge is impressive, but the legal investigation casts a shadow over the management team. While the company boasts exceptional returns on equity and robust revenue growth, the earnings miss and margin pressure suggest execution challenges. The long-term business model is strong, evidenced by a six-year track record of substantial gains, but the short-term path is fraught with volatility and regulatory scrutiny. Investors should weigh the high-quality assets against the governance risks and the current earnings contraction. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.064690 |
| AutoETS | 0.065922 |
| AutoTheta | 0.066053 |
| MSTL | 0.069890 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 2.04 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.943 |
| Excess Kurtosis | -0.13 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 167.496 |
| Revenue per Share | 19.474 |
| Market Cap | 3,056,221,440 |
| Trailing P/E | 23.77 |
| Forward P/E | 38.36 |
| Beta | 1.88 |
| Profit Margins | 22.69% |
| Website | https://www.transmedics.com |
As of Aug. 22, 2026, 3:49 a.m. EDT: Speculators are positioning for continued volatility with a slight bullish skew. Call open interest clusters heavily around the $100 strike, with notable volume spikes at $130 and $150 strikes indicating speculative upside bets. Conversely, put open interest is concentrated in the $60 to $90 range, suggesting defensive hedging against a potential pullback. Implied volatility remains elevated across expirations, reflecting uncertainty surrounding the recent earnings miss and ongoing legal investigations.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.20726132 |
| Address1 | 200 Minuteman Road |
| Address2 | Suite 302 |
| All Time High | 177.37 |
| All Time Low | 10.0 |
| Ask | 87.47 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 1.8 - Buy |
| Average Daily Volume10 Day | 588,490 |
| Average Daily Volume3 Month | 969,026 |
| Average Volume | 969,026 |
| Average Volume10Days | 588,490 |
| Beta | 1.88 |
| Bid | 55.39 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 14.96 |
| City | Andover |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 88.43 |
| Current Ratio | 6.625 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 93.4499 |
| Day Low | 88.37 |
| Debt To Equity | 167.496 |
| Display Name | TransMedics |
| Earnings Call Timestamp End | 1,785,875,400 |
| Earnings Call Timestamp Start | 1,785,875,400 |
| Earnings Growth | -0.558 |
| Earnings Quarterly Growth | -0.579 |
| Earnings Timestamp | 1,785,873,600 |
| Earnings Timestamp End | 1,793,304,000 |
| Earnings Timestamp Start | 1,793,304,000 |
| Ebitda | 115,629,000 |
| Ebitda Margins | 0.17298001 |
| Enterprise To Ebitda | 29.935 |
| Enterprise To Revenue | 5.178 |
| Enterprise Value | 3,461,368,064 |
| Eps Current Year | 1.559 |
| Eps Forward | 2.3055 |
| Eps Trailing Twelve Months | 3.72 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 79.2388 |
| Fifty Day Average Change | 9.1912 |
| Fifty Day Average Change Percent | 0.115993686 |
| Fifty Two Week Change Percent | -20.726131 |
| Fifty Two Week High | 156.0 |
| Fifty Two Week High Change | -67.57 |
| Fifty Two Week High Change Percent | -0.43314102 |
| Fifty Two Week Low | 60.105 |
| Fifty Two Week Low Change | 28.325 |
| Fifty Two Week Low Change Percent | 0.47125864 |
| Fifty Two Week Range | 60.105 - 156.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,556,803,800,000 |
| Float Shares | 33,560,686 |
| Forward Eps | 2.3055 |
| Forward P E | 38.356106 |
| Free Cashflow | 44,496,752 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 898 |
| Fullday Change | -3.32 |
| Fullday Change Percent | -3.61853 |
| Fullday Price | 88.6242 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.58694 |
| Gross Profits | 392,348,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03642 |
| Held Percent Institutions | 1.03216 |
| Implied Shares Outstanding | 34,560,911 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. |
| Long Name | TransMedics Group, Inc. |
| Market | us_market |
| Market Cap | 3,056,221,440 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_429233 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 151,699,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,181,444,553 |
| Number Of Analyst Opinions | 10 |
| Open | 91.87 |
| Operating Cashflow | 145,928,000 |
| Operating Margins | 0.124960005 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.31 |
| Phone | 978 552 0900 |
| Post Market Change | 0.19419861 |
| Post Market Change Percent | 0.21960716 |
| Post Market Price | 88.6242 |
| Post Market Time | 1,787,961,570 |
| Previous Close | 91.75 |
| Price Eps Current Year | 56.722256 |
| Price Hint | 2 |
| Price To Book | 5.911096 |
| Price To Sales Trailing12 Months | 4.571979 |
| Profit Margins | 0.22694 |
| Quick Ratio | 5.869 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.83333 |
| Region | US |
| Regular Market Change | -3.32 |
| Regular Market Change Percent | -3.61853 |
| Regular Market Day High | 93.4499 |
| Regular Market Day Low | 88.37 |
| Regular Market Day Range | 88.37 - 93.4499 |
| Regular Market Open | 91.87 |
| Regular Market Previous Close | 91.75 |
| Regular Market Price | 88.43 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 629,879 |
| Return On Assets | 0.043319996 |
| Return On Equity | 0.36285 |
| Revenue Growth | 0.207 |
| Revenue Per Share | 19.474 |
| Sand P52 Week Change | 0.20204377 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 34,560,911 |
| Shares Percent Shares Out | 0.2281 |
| Shares Short | 7,910,244 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 7,715,332 |
| Short Name | TransMedics Group, Inc. |
| Short Percent Of Float | 0.3552 |
| Short Ratio | 8.19 |
| Source Interval | 15 |
| State | MA |
| Symbol | TMDX |
| Target High Price | 125.0 |
| Target Low Price | 65.0 |
| Target Mean Price | 97.3 |
| Target Median Price | 97.5 |
| Total Cash | 472,675,008 |
| Total Cash Per Share | 13.632 |
| Total Debt | 867,720,000 |
| Total Revenue | 668,467,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.72 |
| Trailing P E | 23.771505 |
| Trailing Peg Ratio | 1.2832 |
| Triggerable | 1 |
| Two Hundred Day Average | 105.541725 |
| Two Hundred Day Average Change | -17.111725 |
| Two Hundred Day Average Change Percent | -0.16213232 |
| Type Disp | Equity |
| Volume | 629,879 |
| Website | https://www.transmedics.com |
| Zip | 1,810 |